Impacts of Endogenous Retroviruses on Tumorigenesis, Immunity, Stem Cells, and Research Safety
Author:
Open Access
- 31 March 2014
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 4, 66
Abstract
Impacts of Endogenous Retroviruses on Tumorigenesis, Immunity, Stem Cells, and Research SafetyKeywords
This publication has 8 references indexed in Scilit:
- Regulation of Mouse Retroelement MuERV-L/MERVL Expression by REX1 and Epigenetic Control of Stem Cell PotencyFrontiers in Oncology, 2014
- Endogenous Mouse Mammary Tumor Viruses (Mtv): New Roles for an Old Virus in Cancer, Infection, and ImmunityFrontiers in Oncology, 2013
- HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial CarcinomaFrontiers in Oncology, 2013
- HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and DiseaseFrontiers in Oncology, 2013
- Endogenous Retroviruses as Targets for Antitumor Immunity in Renal Cell Cancer and Other TumorsFrontiers in Oncology, 2013
- Association of Endogenous Retroviruses and Long Terminal Repeats with Human DisordersFrontiers in Oncology, 2013
- Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell LinesFrontiers in Oncology, 2013
- Infection of Xenotransplanted Human Cell Lines by Murine Retroviruses: A Lesson Brought Back to Light by XMRVFrontiers in Oncology, 2013